The DOI matches its Crossref record.
Bioactivity of Metallothionein-3 Correlates with Its Novel .beta. Domain Sequence Rather Than Metal Binding Properties
Abstract
Human and mouse metallothionein-3 (MT-3) molecules exhibit the same metal binding stoichiometry with Zn(II), Cd(II), or Cu(I) as MT-1 or MT-2 molecules, suggesting that MT-3 consists of two domains enfolding separate polymetallic clusters. The kinetic reactivities of Zn(II) complexes of MT-3 with the chelator ethylenediaminetetraacetic acid (EDTA) or the thiol reagent dithiobis(2-nitrobenzoic acid) (DTNB) resembles the reactivity of ZnMT-1. Furthermore, the candidate alpha and beta domain peptides of human MT-3 are very similar to MT-1 domain peptides in the reactivity of Zn(II) complexes. Zn(II) complexes of human and mouse MT-3 inhibit the survival of rat cortical neurons cultured in the presence of an Alzheimer's disease brain extract. Inhibitory activity is unique to the MT-3 isoform and is a property of the N-terminal beta domain. The inhibitory activity of the 32-residue MT-3 beta domain is abolished by a double mutation within the beta domain resulting in the conversion of the C-P-C-P sequence to either C-S-C-A or C-T-C-T. Thus, the bioactivity arises from a novel structure of the N-terminal beta domain of MT-3 and not any unusual metal-binding properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Metallothionein: the multipurpose protein
Coyle, P., Philcox, J. C., Carey, L. C., & Rofe, A. M. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8454-2 · Cited by 1,304
The elusive function of metallothioneins
Palmiter, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8428 · Cited by 679
Self-citationMetallothioneins: new functional and structural insights
Vasák, M. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00082-x · Cited by 412
Roles of the metallothionein family of proteins in the central nervous system
Hidalgo, J., Aschner, M., Zatta, P., & Vašák, M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00452-x · Cited by 387
Guo, Z., & Sadler, P. J. (1999) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60271-8 · Cited by 354
Advances in the structure and chemistry of metallothioneins
Romero-Isart, N., & Vašák, M. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00347-6 · Cited by 279
Chemistry and biology of mammalian metallothioneins
Vašák, M., & Meloni, G. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0799-2 · Cited by 268
Metallothionein in the central nervous system: Roles in protection, regeneration and cognition
West, A. K., Hidalgo, J., Eddins, D., Levin, E. D., & Aschner, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.12.006 · Cited by 190
“…as GAP43 (Benowitz and Routtenberg, 1997; Bibel M, 2000), which would support an inhibitory role of MT-III in line with some in vitro bioassays (Chung et al., 2002a; Chung et al., 2002; Chung et al., 2003b; Chung and West, 2004b; Erickson et al., 1994; Sewell et al., 1995; Uchida et al., 1991b).”
BackgroundSewell, A. K., Yokoya, F., Yu, W., Miyagawa, T., Murayama, T., & Winge, D. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.25079 · Cited by 61
Self-citation
Metadata
- Authors
- Sewell, A. K., Jensen, L. T., Erickson, J. C., Palmiter, R. D., & Winge, D. R.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-04-11
- Volume
- 34
- Issue
- 14
- Pages
- 4740-4747
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1995968305
- Cited by
- 161
- References
- 0
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.